This is a news story, published by Interesting Engineering, that relates primarily to Cushing news.
For more longevity news, you can click here:
more longevity newsFor more news from Interesting Engineering, you can click here:
more news from Interesting EngineeringOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about longevity, you might also like this article about
new longevity therapies. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Mifepristone Risk Evaluation news, lifespan news, news about longevity, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
mifepristoneInteresting Engineering
•
74% Informative
Scientists say mifepristone, used in cancer and reproductive care, could pave the way for anti-aging treatments.
The drug is best known for its use for ending early pregnancies.
It is also used to treat Cushing ’s disease and certain cancers.
Researchers focused on mitophagy to understand how the drugs might extend lifespan.
VR Score
67
Informative language
63
Neutral language
40
Article tone
formal
Language
English
Language complexity
70
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links